Want to see SE:SERT full AI Analyst Report?
Top Page
Serstech AB
(SERT)
Select Model
Select Model
Rating:43Neutral
Price Target:
kr0.50
▼(-14.48% Downside)
Action:Reiterated
Date:09/19/26
The score is primarily held down by weak financial performance—large ongoing losses and significant negative operating/free cash flow—despite some balance-sheet buffer and TTM revenue growth. Technicals are largely neutral with slightly negative momentum, and valuation provides limited support because earnings are negative and no dividend yield is available.
Positive Factors
TTM Revenue Growth
Revenue growth and the return to positive gross profit indicate that customer demand and product-level economics have some underlying support. If maintained, this can provide a foundation for operating leverage, although the current cost base still prevents that growth from translating into profits.
Negative Factors
Severe Ongoing Losses
The scale of current losses shows that revenue and gross profit are not covering the company’s operating cost base. Persistent negative earnings can erode equity, restrict internal funding capacity, and make improvement dependent on a substantial recovery in operating efficiency.
Read all positive and negative factors
Positive Factors
Negative Factors
TTM Revenue Growth
Revenue growth and the return to positive gross profit indicate that customer demand and product-level economics have some underlying support. If maintained, this can provide a foundation for operating leverage, although the current cost base still prevents that growth from translating into profits.
Read all positive factors
Serstech AB (SERT) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr141.40M
Dividend YieldN/A
Average Volume (3M)139.53K
Price to Earnings (P/E)―
Beta (1Y)0.40
Revenue Growth-26.35%
EPS Growth-5.95%
CountrySE
Employees26
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)N/A
Shares Outstanding254,319,050
10 Day Avg. Volume213,654
30 Day Avg. Volume139,532
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)3.02
Price to Sales (P/S)3.75
P/FCF Ratio-3.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Serstech AB Business Overview & Revenue Model
Company Description
Founded in 2006 and headquartered in Lund, Sweden, Serstech AB is a global provider of advanced chemical identification instruments. The company's offerings include the compact, lightweight, handheld Serstech 100 Indicator, a Raman spectrometer ca...
How the Company Makes Money
Serstech AB primarily makes money by selling its chemical identification products (portable/handheld analyzers) and associated software used to detect and identify substances in operational environments. Revenue is generated from (1) product sales...
Serstech AB Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
44
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.31M | 38.59M | 52.26M | 62.76M | 25.89M | 18.65M |
| Gross Profit | 25.05M | -20.80M | 38.33M | 48.44M | 21.71M | 15.53M |
| EBITDA | -19.35M | -20.59M | -8.78M | 12.98M | -30.03M | -9.77M |
| Net Income | -28.96M | -29.27M | -9.13M | 715.00K | -29.57M | -10.25M |
Balance Sheet | ||||||
| Total Assets | 58.33M | 57.49M | 94.72M | 59.71M | 52.55M | 66.56M |
| Cash, Cash Equivalents and Short-Term Investments | 4.17M | 9.76M | 9.29M | 18.47M | 1.87M | 19.57M |
| Total Debt | 10.00M | 0.00 | 0.00 | 1.80M | 4.74M | 1.70M |
| Total Liabilities | 22.31M | 9.71M | 18.16M | 11.74M | 25.93M | 10.45M |
| Stockholders Equity | 36.02M | 47.79M | 76.56M | 47.97M | 26.62M | 56.11M |
Cash Flow | ||||||
| Free Cash Flow | -34.09M | -37.41M | -8.49M | -1.37M | -20.75M | -13.19M |
| Operating Cash Flow | -24.79M | -28.02M | 562.00K | 7.63M | -13.16M | -628.00K |
| Investing Cash Flow | -9.30M | -9.40M | -7.95M | -9.00M | -7.59M | -12.55M |
| Financing Cash Flow | 10.29M | 37.88M | -1.80M | 17.98M | 3.04M | 21.36M |
Serstech AB Technical Analysis
Positive
0.58
Price Trends
0.53
Positive
0.50
Positive
0.50
Positive
Market Momentum
<0.01
Negative
56.91
Neutral
84.48
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SERT, the sentiment is Positive. The current price of 0.58 is above the 20-day moving average (MA) of 0.53, above the 50-day MA of 0.53, and above the 200-day MA of 0.50, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.91 is Neutral, neither overbought nor oversold. The STOCH value of 84.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:SERT.
Serstech AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | kr784.65M | 10.56 | 10.54% | 4.35% | -13.36% | -31.32% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | kr268.53M | -14.15 | -8.17% | ― | -1.90% | -13.63% | |
52 Neutral | kr121.63M | 41.04 | 1.04% | 8.11% | -14.23% | 84.80% | |
45 Neutral | kr145.62M | -8.03 | -27.51% | ― | 36.35% | 38.34% | |
43 Neutral | kr141.40M | -4.93 | -63.36% | ― | -26.35% | -5.95% | |
41 Neutral | kr51.12M | -0.91 | -176.65% | ― | -21.95% | -28.77% |
* Basic Materials Sector Average
SE:SERT
Serstech AB
0.55
0.03
5.73%
SE:NEXAM
Nexam Chemical Holding AB
2.62
-1.08
-29.19%
SE:POLYG
Polygiene AB
3.30
-4.90
-59.76%
SE:AXIC.A
aXichem AB Class A
2.00
-1.07
-34.79%
SE:ORGC
OrganoClick AB
0.28
-1.45
-84.05%
SE:ARPL
Arla Plast AB
36.75
-21.60
-37.01%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.